Remote informed consent for a 14-site biospecimen collection study by a US brain disorders research consortium

The client is a non-profit consortium led by 25+ patient advocacy foundations, working with clinicians, researchers, and pharmaceutical firms that develop treatments for the brain disorders they represent.